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Abstract
Background: In addition to outbreaks of nosocomial influenza, sporadic nosocomial influenza infections also occur
but are generally not reported in the literature.
This study aimed to determine the epidemiologic characteristics of cases of nosocomial influenza compared with
the remaining severe cases of severe influenza in acute hospitals in Catalonia (Spain) which were identified by
surveillance.
Methods: An observational case-case epidemiological study was carried out in patients aged ≥18 years from
Catalan 12 hospitals between 2010 and 2016. For each laboratory-confirmed influenza case (nosocomial or not) we
collected demographic, virological and clinical characteristics. We defined patients with nosocomial influenza as
those admitted to a hospital for a reason other than acute respiratory infection in whom ILI symptoms developed
≥48 h after admission and influenza virus infection was confirmed using RT-PCR. Mixed-effects regression was used
to estimate the crude and adjusted OR.
Results: One thousand seven hundred twenty-two hospitalized patients with severe laboratory-confirmed influenza
virus infection were included: 96 (5.6%) were classified as nosocomial influenza and more frequently had > 14 days
of hospital stay (42.7% vs. 27.7%, P < .001) and higher mortality (18.8% vs. 12.6%, P < .02). The variables associated
with nosocomial influenza cases in acute-care hospital settings were chronic renal disease (aOR 2.44 95% CI 1.44–
4.15) and immunodeficiency (aOR 1.79 95% CI 1.04–3.06).
Conclusions: Nosocomial infections are a recurring problem associated with high rates of chronic diseases and
death. These findings underline the need for adherence to infection control guidelines.
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Background
Each year, 5–20% of the population are infected by the
influenza virus [1]. Among adults aged ≥65 years and pa-
tients with underlying chronic diseases influenza is a
leading cause of severe illness and death. Sentinel sur-
veillance of patients hospitalized due to severe
laboratory-confirmed influenza is critical to control the
timing and spread of influenza and detect variations in
circulating influenza viruses [2, 3].
The Department of Health of Catalonia (Spain) intro-
duced the surveillance of patients hospitalized with
laboratory-confirmed influenza to supplement the infor-
mation provided by the influenza sentinel surveillance
system, based on primary healthcare physicians, in Octo-
ber 2010 [4]. During periods of increased influenza activ-
ity in the community and the subsequent increase in the
number of patients with influenza in hospitals, the risk
of nosocomial transmission from infected patients in-
creases [5].
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Nosocomial influenza is a recognized public health
problem in acute-care hospital settings [5] and has been
associated with significant morbidity, mortality and high
economic costs due to longer hospital stays. It is likely
to be under-recognized due to rapid patient turnover
and delays in diagnosis.
Outbreaks of influenza have been reported in different
hospital wards [6–11]. In addition, sporadic nosocomial
influenza infections may occur but are generally not
identified or reported [5].
This study aimed to determine the epidemiologic char-
acteristics of nosocomial influenza cases in acute-care
hospital settings in Catalonia (Spain) identified by sur-
veillance rather than through outbreak control activity
during six consecutive influenza seasons (2010–2011 to
2015–2016).
Methods
Epidemiological study
The general methods of this study have been published
elsewhere [12, 13]. In summary, we conducted an obser-
vational case-case epidemiological study of the charac-
teristics and risk factors of nosocomial influenza cases in
patients hospitalized due to laboratory-confirmed influ-
enza in acute-care hospital settings.
Catalonia (Spain) initiated, in 2010, the surveillance of
patients hospitalized due to laboratory-confirmed influ-
enza. The system included a catchment area of 4,644,
543 persons. During each influenza season, the 12 hospi-
tals included in the surveillance system report on pa-
tients hospitalized with severe laboratory-confirmed
influenza admitted to one of these hospitals.
Study population and data collected
The study population was reported cases aged ≥18 years
hospitalized with severe laboratory-confirmed influenza
virus infection during six influenza seasons (2010–2011
to 2015–2016). We included patients hospitalized ≥24 h
in any participating hospitals who presented an
influenza-like-illness (ILI). A sentinel physician who
screened all patients with severe ILI enlisted patients in
each participating hospital. All patients had a nasopha-
ryngeal or throat swab (bronchoalveolar lavage fluid or
tracheal aspirate for intensive care unit (ICU) patients)
and influenza virus infection was detected using reverse
transcription polymerase chain reaction (RT-PCR).
From this source of acute-care hospital influenza pa-
tients, we defined patients with nosocomial influenza as
those admitted to a hospital for a reason other than
acute respiratory infection in whom ILI symptoms devel-
oped ≥48 h after admission and influenza virus infection
was confirmed using RT-PCR.
A structured questionnaire was used by public health of-
ficers to collect data from each reported case by interview
and review of medical records. This included socio-
demographic data, obesity (body mass index [BMI] > 40),
pregnancy, major chronic conditions (chronic obstructive
pulmonary disease [COPD]), diabetes, chronic renal dis-
ease, immunodeficiency (HIV infection or other), chronic
cardiovascular disease, and chronic liver disease).
Laboratory data
Patient samples were first tested in the laboratories of the
participating hospitals using an in-house real-time RT-PCR
for influenza A and B after manual nucleic acid extraction.
Samples with unsubtyped influenza virus were sent to the
Catalan Influenza Reference Laboratory to determine the
subtype. Molecular subtyping was used to determine the H
subtype for influenza A and the lineage for influenza B.
Subtyping failed in some cases due to a low viral load and
such samples were classified as “unidentifiable”.
Statistical analysis
We compared the baseline characteristics of nosocomial
influenza cases with those of other hospitalized cases of
severe influenza. The baseline variables considered were:
sex, age (18–64, 65–74 and ≥ 75 years), virus type, major
chronic conditions (COPD, diabetes, obesity [BMI > 40],
chronic renal disease, immunodeficiency [HIV infection
or other]), chronic cardiovascular disease, and chronic
liver disease), complications, hospital stay, seasonal influ-
enza, and antiviral treatment. The chi-square test and
Fisher’s exact test were used for categorical variables and
the median test for continuous variables.
The length of stay was calculated as from the first day
of hospital admission in patients with community-
acquired influenza and from the onset of influenza
symptoms in patients with nosocomial influenza. To as-
sess the relationships between the dependent variable
(nosocomial influenza cases Yes/No) and the independ-
ent variables studied, a case-case bivariate analysis was
made. Possible interactions between independent vari-
ables were analyzed by logistic regression. Independent
variables were checked for collinearity using the variance
inflation factor. Because there were differences between
hospitals in nosocomial influenza cases, a mixed-effects
logistic regression model with the variable hospital as a
random intercept was constructed to estimate the crude
and adjusted odds ratios (OR) and their corresponding
95% confidence intervals (CI). A multivariate analysis
was performed using the mixed-effects logistic regres-
sion model that included the variables described. The
final model was selected using the backward procedure,
with a cut-off point of p < 0.2.
Ethics approval and consent to participate
As this study was undertaken as part of a national sur-
veillance system, ethical approval was not required [14].
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Results
A total of 1722 patients aged ≥18 years hospitalized with
laboratory-confirmed influenza were recorded: 805
(46.7%) were aged 18–64 years and 917 (53.3%) ≥ 65
years and 743 (43.1%) were female. During the six sea-
sons studied, 1480 (85.9%) patients were infected with
influenza A viruses (572 H1N1 and 331 H3N2) and 241
(14%) with influenza B viruses.
Of the 1722 patients, 96 (5.6%) were admitted to a
hospital for a reason other than acute respiratory infec-
tion and developed ILI symptoms ≥48 h after admission
and were classified as nosocomial influenza. Of these 96
cases, 35 (36.5%) were aged 18–64 years, 22 (22.9%) were
aged 64–74 years, 39 (40.6%) ≥ 75 years and 43 (44.8%)
were female. Eighty (83.3%) patients presented ≥1 influ-
enza risk factor and 36 (37.5%) had received the influ-
enza vaccine (Table 1).
There were differences between nosocomial influenza
patients and those who were not. Nosocomial influenza
cases had a higher frequency of age 65–74 years (22.9%
vs. 18.8%, P < .13), and ≥ 75 years (40.6% vs. 33.9%,
P < .15), diabetes (35.4% vs. 24.4%, P = .02), chronic renal
disease (29.2% vs. 12.8% P < .001), immunodeficiency
(28.1% vs. 18.9% P < .001), chronic cardiovascular disease
(39.6% vs. 28.8% P < .02) and chronic liver disease (8.3%
vs. 6.4% P = .25). Influenza vaccination uptake was
higher in nosocomial influenza patients (37.5% vs. 25.6%,
P = .03) (Table 1).
Likewise, nosocomial influenza patients more fre-
quently received antiviral treatment within 48 h of symp-
tom onset (67.4% vs. 23.9%, P = .01) and had a lower
frequency of pneumonia (54.2% vs. 76.4%, P < .001).
However, nosocomial influenza patients required more
days of hospital stay (median: 13 (2–76) vs. 9 (0–137),
P = .001) and a higher mortality rate was observed
(18.8% vs. 12.6%, P < .02) (Table 2). No interaction was
found between the variables investigated, and there was
no collinearity between the variables.
In the multivariable regression model, the variables as-
sociated with nosocomial influenza cases were chronic
renal disease (aOR 2.44 95% CI 1.44–4.15) and immuno-
deficiency (aOR 1.79 95% CI 1.04–3.06) (Table 3).
Nosocomial influenza cases were a risk factor for death
(OR 1.86 95% CI 1.07–3.23). Furthermore, in the multi-
variable regression model the risk of death was slightly
higher (aOR 3.26 95% CI 1.53–6.92) after adjustment for
the other variables in the model (Table 4).
Discussion
This study, based on the surveillance of hospitalized
cases of severe laboratory-confirmed influenza, shows
that 5.65% of influenza cases in acute hospitals were due
to nosocomial transmission and were associated with
chronic diseases and a high risk of death. The results
highlight the importance of the nosocomial transmission
of influenza in acute hospitals in a study with a multi-
center design, a large number of patients and an ex-
tended study period of six consecutive influenza seasons.
Our results are consistent with other studies that show
sporadic nosocomial cases of influenza are a public
health problem in acute-care hospital settings. Enstone
et al. in the United Kingdom detected 30 nosocomial
cases (2.0%) in 1520 hospitalized patients with influenza
from 75 hospitals [15]; Macesic et al. in Australia re-
corded 26 nosocomial cases (4.3%) in 598 hospitalized
patients with influenza from 15 hospitals [16]; and Álva-
rez-Lerma et al in Spain documented 224 nosocomial
cases (9.3%) in 2421 hospitalized patients with influenza
from 148 intensive care units [17]. Patients with
hospital-acquired influenza infection had a profile that
differed from that of patients with community-acquired
infections; they were older, more likely to have chronic
diseases (diabetes, chronic renal disease, immunodefi-
ciency and chronic cardiovascular disease) and had
higher mortality (18.8%). Similarly, other studies present
poor outcomes. While the mortality of nosocomial cases
in the study by Enstone et. al was 26.7% [15], in the
study by Álvarez-Lerma et al. it was 39.2% [17]; in both
studies mortality was notably higher than that due to
community-acquired influenza [15, 17]. Compared with
community-acquired influenza cases, we found a signifi-
cantly longer stay in patients with nosocomial influenza.
Nosocomial influenza has previously been associated
with longer hospitalization as well as increased use of
diagnostic resources and treatments [5].
Even though vaccination rates were very low in pa-
tients with both hospital-acquired and community-
acquired influenza virus infection, a higher proportion of
nosocomial influenza patients had been vaccinated. This
has been observed in other studies [15–17] and may be
related to the greater number of comorbidities (COPD,
diabetes, chronic renal disease, immunodeficiency and
chronic cardiovascular disease) for which vaccination is
recommended [18].
As with nosocomial influenza outbreaks [19, 20], spor-
adic nosocomial cases of influenza detected by surveil-
lance during the influenza season may have special
interest, as they could suggest failures in hospital infec-
tion control. The case series in this study was detected
in settings where clinical management and infection
control precautions were determined by guidelines [21],
and with data recorded by experienced public health
staff [4].
There is no standardized definition of nosocomial in-
fluenza infection. The mean hospital stay before symp-
tom onset in this study was 14.3 days and we applied a
cutoff point of ≥2 days after admission in nosocomial
cases. This case definition was based on a review of
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health care-associated influenza that showed a median
threshold delay between admission and symptom onset
of 48 h (range: 24–96 h) [22, 23], suggesting that the er-
roneous inclusion of community cases of influenza as
nosocomial cases is quite improbable. Nevertheless, a
standardized definition is lacking, and this should be re-
solved in the future.
Health care-associated influenza cases could signal
failures in hospital infection control, as transmission
may have been due to an infectious health care worker
[24] or to the contaminated hands of a health care
worker [5]. However, infection by other patients could
also have occurred. Munier-Marion et al. reported that
hospitalizations in double-occupancy rooms are an
Table 1 Demographic characteristics and comorbidities of patients with community-acquired or nosocomial influenza, Catalonia
(Spain)
Variables Hospital acquired
(N = 96)
Community acquired
(N = 1626)
Crude OR
(95% CI)
P value
Age
18–64 35 (36.5%) 770 (47.4%) Ref.
65–74 22 (22.9%) 305 (18.8%) 1.53 (0.88–2.66) 0.13
> =75 39 (40.6%) 551 (33.9%) 1.42 (0.88–2.29) 0.15
Sex
Female 43 (44.8%) 700 (43.1%) 1.07 (0.70–1.62) 0.75
Male 53 (55.2%) 926 (56.9%) Ref.
COPD
Yes 26 (27.1%) 414 (25.5%) 1.06 (0.68–1.70) 0.79
No 70 (72.9%) 1212 (74.5%) Ref.
Obesity
Yes 14 (14.6%) 168 (10.3%) 1.29 (0.71–2.35) 0.41
No 82 (85.4%) 1458 (89.7%) Ref.
Diabetes
Yes 34 (35.4%) 396 (24.4%) 1.66 (1.07–2.57) 0.02
No 62 (64.6%) 1230 (75.6%) Ref.
Chronic renal disease
Yes 28 (29.2%) 208 (12.8%) 3.05 (1.89–4.92) < 0.001
No 68 (70.8%) 1418 (87.2%) Ref.
Immunodeficiency
Yes 27 (28.1%) 307 (18.9%) 1.96 (1.21–3.17) 0.01
No 69 (71.9%) 1319 (81.1%) Ref.
Heart disease
Yes 38 (39.6%) 469 (28.8%) 1.67 (1.09–2.57) 0.02
No 58 (60.4%) 1157 (71.2%) Ref.
Liver disease
Yes 8 (8.3%) 1034 (6.4%) 1.57 (0.73–3.37) 0.25
No 88 (91.7%) 1522 (93.6%) Ref.
Virus type
A 79 (82.3%) 1401 (86.1%) Ref.
B 17 (17.7%) 224 (13.8%) 1.49 (0.86–2.59) 0.15
C 0 (0.0%) 1 (0.1%) – –
Seasonal influenza vaccination
Yes 36 (37.5%) 412 (25.6%) 1.62 (1.05–2.52) 0.03
No 60 (62.5%) 1198 (74.4%) Ref.
OR Odds ratio, CI Confidence interval
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important risk factor for hospital-acquired influenza
[25]. Another possibility may be transmission from pa-
tients’ visitors [5, 25].
Strategies to reduce influenza transmission in health
facilities should include different methods. Patients with
risk factors should be vaccinated before the start of the
influenza season. In addition, all their contacts and
health care workers should also be vaccinated. Barrier
precautions, compliance with hand hygiene and exclu-
sion of sick workers should also be ensured. The influ-
enza vaccine is recommended and funded for older
people and risk groups in most European countries, al-
though its effectiveness is not absolute [18]. Reducing
transmission from advising of not working or not visit-
ing hospitals when people are sick and applying barrier
precautions has some limitations due to the possibility
of influenza transmission before the onset of symptoms
or with minimal symptomatology [24]. Nevertheless,
together these measures may help reduce the number of
acquired-hospital influenza cases. Furthermore, the
study suggested a high risk of death in elderly patients
with nosocomial influenza with chronic renal disease or
immunosuppressive diseases and those with stem cell
transplantation or cancer. Health care workers caring for
these patients should be vaccinated every season and
mandatory vaccination may be considered.
Our study is based on a case-case analysis of patients
hospitalized with severe laboratory-confirmed influenza.
The strengths of the study include the large number of
patients hospitalized for influenza, the multicenter de-
sign, the uniform patient screening by hospitals, the diag-
nostic confirmation of all patients and the extended
study period of six consecutive influenza seasons.
However, the study has also limitations. Some patients
may have been discharged before the onset of hospital-
acquired influenza. Furthermore, some patients may
Table 2 Antiviral treatment, complications and risk of death in patients with community-acquired and nosocomial influenza,
Catalonia (Spain)
Variables Hospital acquired
(N = 96)
Community acquired
(N = 1626)
Crude OR
(95% CI)
P value
Antiviral treatment
Yes 89 (92.7%) 1485 (91.3%) 1.06 (0.48–2.34) 0.89
No 7 (7.3%) 141 (8.7%) Ref.
Antiviral treatment
≤ 48 h before symptom onset 62 (67.4%) 375 (23.9%) 2.94 (1.30–6.66) 0.01
> 48 h before symptom onset 23 (25.0%) 1051 (67.1%) 0.42 (0.18–1.00) 0.05
No 7 (7.6%) 141 (9.0%) Ref.
Hospital stay; median (range) 13 (2–76) 9 (0–137) 0.001
Hospital stay
0–14 days 55 (57.3%) 1174 (72.3%) Ref.
> 14 days 41 (42.7%) 450 (27.7%) 2.04 (1.33–3.14) < 0.001
Pneumonia
Yes 52 (54.2%) 1237 (76.4%) 0.34 (0.22–0.53) < 0.001
No 44 (45.8%) 383 (23.6%) Ref.
ARDS
Yes 33 (34.4%) 626 (39.3%) 0.86 (0.52–1.42) 0.57
No 63 (65.6%) 965 (60.7%) Ref.
Multiorgan failure
Yes 10 (10.6%) 166 (10.5%) 1.10 (0.56–2.19) 0.78
No 84 (89.4%) 1416 (89.5%) Ref.
ICU admission
Yes 31 (32.3%) 561 (34.5%) 1.00 (0.64–1.56) 0.99
No 65 (67.7%) 1065 (65.5%) Ref.
Death
Yes 18 (18.8%) 205 (12.6%) 1.91 (1.11–3.31) 0.02
No 78 (81.3%) 1421 (87.4%) Ref.
ARDS Acute respiratory distress syndrome, ICU Intensive care unit, OR Odds ratio, CI Confidence interval
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have minor symptoms which might not be detected and
therefore the real number of nosocomial cases might
have been underestimated.
Conclusions
This study shows that nosocomial transmission is a re-
current problem and the total effect of nosocomial
influenza may be underestimated. These results suggest
the need to improve infection control guidelines and the
vaccination of health care workers and ensure clinical
suspicion of influenza in high risk areas. In addition,
people should be recommended not to visit hospitals
when they are ill.
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